Enara Bio

Advancing cancer immunotherapy by targeting the unconventional

Oxford, United Kingdom · $32.5M raised

Headquarters
Oxford
Employees
51–200
Business Model
B2B
Total Funding
$32.5M
Last Round
$32.5M Series BOct 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Enara Bio is an Oxford, UK-based biopharmaceutical company pioneering the discovery and validation of 'Dark Antigens,' a novel class of cancer-specific targets derived from previously uncharacterized non-coding regions of the genome. Through its proprietary EnTiCE platform, the company develops first-in-class bispecific T-cell engager immunotherapies and has formed partnerships with Boehringer Ingelheim and the Francis Crick Institute, backed by investors including RA Capital, Pfizer Ventures, and SV Health Investors.

Summary

Enara Bio is a Biotech company based in Oxford, United Kingdom. It has raised $32.5M in total across 1 round, most recently a $32.5M Series B round in Oct 2024. Investors include Pfizer Ventures, M Ventures and Samsara BioCapital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BOct 2024
$32.5M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Enara Bio on Indexed.vc
<a href="https://indexed.vc/companies/enara-bio"><img src="https://indexed.vc/api/badge/company/enara-bio" alt="Enara Bio on Indexed.vc" width="260" height="76" /></a>